• NATIONAL TELEMEDICINE PORTAL
  • TELEMEDICINE DIVISION
  • MINISTRY OF HEALTH & FAMILY WELFARE
  • GOVERNMENT OF INDIA

Video List of Webinar :'Advanced Level Training Workshop in Pharmacovigilance'

Total Count : 9
S no Name of Webinar Name of Faculty Title of Lecture Institute Link

1

Advanced Level Training Workshop in Pharmacovigilance

Dr Sangeeta Ravat

Advanced Level Training Workshop in Pharmacovigilance King Edward Memorial (KEM), Mumbai

2

Advanced Level Training Workshop in Pharmacovigilance

Dr Rajeev Singh Raghuvanshi Secretary cum Scientific Director, IPC

Pharmacovigilance Program of India [PvPI]- a perspective from Indian Pharmacopoeia Commission [IPC] King Edward Memorial (KEM), Mumbai

3

Advanced Level Training Workshop in Pharmacovigilance

Dr Nilima Kshirsagar Chairperson, Core Training Panel, IPC

Introduction to the Core Training Panel King Edward Memorial (KEM), Mumbai

4

Advanced Level Training Workshop in Pharmacovigilance

Dr Tanu Singhal Consultant in Pediatrics Kokilaben Hospital, Mumbai

Benefit risk analysis with repurposed drugs in COVID -19 – a clinician’s perspective King Edward Memorial (KEM), Mumbai

5

Advanced Level Training Workshop in Pharmacovigilance

Dr Suparna Chatterjee Professor, IPGMER, Kolkata

Principles and methods of vaccine signal detection King Edward Memorial (KEM), Mumbai

6

Advanced Level Training Workshop in Pharmacovigilance

Dr Sunita Chappola Shukla Director, Mumbai Allergy Center

Drug and vaccine allergy – generating real world evidence King Edward Memorial (KEM), Mumbai

7

Advanced Level Training Workshop in Pharmacovigilance

Dr Vivek Ahuja Sun Pharma

Shaping benefit -risk with automation and AI – a peek into the future of Pharmacovigilance King Edward Memorial (KEM), Mumbai

8

Advanced Level Training Workshop in Pharmacovigilance

Dr Viraj Rajadhyaksha Astra Zeneca, UK

Assessing benefit -risk in the real world with the Chadox 1 COViD-19 vaccine King Edward Memorial (KEM), Mumbai

9

Advanced Level Training Workshop in Pharmacovigilance

Dr Robin Ferner Clinical Pharmacologist, City Hospital, Birmingham

Benefit - risk assessment with Mefloquine – A UK perspective King Edward Memorial (KEM), Mumbai